Literature DB >> 2936965

Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.

G Engel, M Göthert, D Hoyer, E Schlicker, K Hillenbrand.   

Abstract

In rat brain cortex slices preincubated with [3H]5-HT, the potencies of 17 5-HT receptor agonists to inhibit the electrically evoked 3H overflow and the affinities of 13 antagonists (including several beta-adrenoceptor blocking agents) to antagonize competitively the inhibitory effect of unlabelled 5-HT on evoked 3H overflow were determined. The affinities of the compounds for 5-HT1B and 5-HT2 binding sites in rat brain cortex membranes (labelled by [125I]cyanopindolol = [125I]-CYP in the presence of 30 mumol/l isoprenaline and [3H]ketanserin, respectively), for 5-HT1A binding sites in pig and rat brain cortex membranes (labelled by [3H]8-hydroxy-2-(di-n-propylamino)tetralin = [3H]8-OH-DPAT) and for 5-HT1C binding sites in pig choroid plexus membranes (labelled by [3H]mesulergine) were also determined. The affinities of the drugs for the various 5-HT recognition sites ranged over 4-5 log units (the functional experiments revealed the same range of differences between the drugs). There were no significant correlations between the affinities of the drugs at 5-HT1C and 5-HT2 binding sites and their potencies or affinities, determined for the 5-HT autoreceptors. In contrast, significant correlations were found between the potencies or affinities of the drugs for the autoreceptors and their affinities at 5-HT1A or 5-HT1B binding sites; the best correlations were obtained with the 5-HT1B binding site. Some of the drugs investigated were not included in the correlation since their agonistic or antagonistic effects on the autoreceptors were weak and pEC30 or apparent pA2 values could not be determined (less than 5.5).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936965     DOI: 10.1007/bf00633189

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.

Authors:  D Hoyer; G Engel; H O Kalkman
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

2.  Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex.

Authors:  M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

3.  Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting.

Authors:  H A Feldman
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

4.  Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex.

Authors:  E Schlicker; M Göthert; K Hillenbrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

5.  Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol.

Authors:  D N Middlemiss
Journal:  Eur J Pharmacol       Date:  1984-06-01       Impact factor: 4.432

6.  Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.

Authors:  S Z Langer; C Moret
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

7.  Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices.

Authors:  M Göthert; G Weinheimer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

8.  Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.

Authors:  W J Vaatstra; W M Deiman-Van Aalst; L Eigeman
Journal:  Eur J Pharmacol       Date:  1981-03-12       Impact factor: 4.432

9.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT.

Authors:  H Gozlan; S El Mestikawy; L Pichat; J Glowinski; M Hamon
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

10.  3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic.

Authors:  W U Dompert; T Glaser; J Traber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

View more
  136 in total

1.  Dominant role of the cytosolic C-terminal domain of the rat 5-HT1B receptor in axonal-apical targeting.

Authors:  N Jolimay; L Franck; X Langlois; M Hamon; M Darmon
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

2.  SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.

Authors:  J Watson; C Roberts; C Scott; I Kendall; L Collin; N C Day; M H Harries; E Soffin; C H Davies; A D Randall; T Heightman; L Gaster; P Wyman; C Parker; G W Price; D N Middlemiss
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

3.  An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex.

Authors:  Lotte de Groote; André A Klompmakers; Berend Olivier; Herman G M Westenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-24       Impact factor: 3.000

4.  Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors.

Authors:  I Cloëz-Tayarani; A Cardona; J C Rousselle; O Massot; L Edelman; G Fillion
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

6.  The effects of ageing on prejunctional 5-hydroxytryptamine receptors in the rat vas deferens.

Authors:  M Borton; J R Docherty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

7.  Characterization of the 5-hydroxytryptamine receptors mediating contraction in the pig isolated intravesical ureter.

Authors:  Medardo Hernández; María Victoria Barahona; Ulf Simonsen; Paz Recio; Luis Rivera; Ana Cristina Martínez; Albino García-Sacristán; Luis M Orensanz; Dolores Prieto
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain.

Authors:  P Blier; Y Chaput; C de Montigny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

9.  Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex.

Authors:  E Schlicker; M Göthert; K Hillenbrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

10.  G protein dependent alterations in [125I]iodocyanopindolol and +/- cyanopindolol binding at 5-HT1B binding sites in rat brain membranes.

Authors:  K Ariani; M W Hamblin; G L Tan; C A Stratford; R D Ciaranello
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.